C9ORF72 hexanucleotide repeat expansion: From ALS and FTD to a broader pathogenic role?

被引:3
|
作者
Sellier, C. [1 ]
Corcia, P. [2 ,3 ]
Vourc'h, P. [2 ,4 ]
Dupuis, L. [1 ]
机构
[1] Univ Strasbourg, Inserm, UMR S1329, Ctr Rech Biomd Strasbourg, Strasbourg, France
[2] Univ Tours, UMR iBrain 1253, Inserm, Tours, France
[3] CHU Bretonneau, Ctr Constitut Coordinat SLA, 2 Blvd Tonnelle, F-37044 Tours 1, France
[4] CHU Tours, Serv Biochim & Biol Mol, Tours, France
关键词
Amyotrophic lateral sclerosis; C9ORF72; Phenotype; Pathophysiology; AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; RNA FOCI; GGGGCC REPEAT; ANTISENSE TRANSCRIPTS; RAN TRANSLATION; CPG-ISLAND; PROTEINS; DISEASE; GENE;
D O I
10.1016/j.neurol.2024.03.008
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The major gene underlying monogenic forms of amyotrophic lateral sclerosis (ALS) and fronto-temporal dementia (FTD) is C9ORF72. The causative mutation in C9ORF72 is an abnormal hexanucleotide (G4C2) repeat expansion (HRE) located in the first intron of the gene. The aim of this review is to propose a comprehensive update on recent developments on clinical, biological and therapeutics aspects related to C9ORF72 in order to highlight the current understanding of genotype -phenotype correlations, and also on biological machinery leading to neuronal death. We will particularly focus on the broad phenotypic presentation of C9ORF72-related diseases, that goes well beyond the classical phenotypes observed in ALS and FTD patients. Last, we will comment the possible therapeutical hopes for patients carrying a C9ORF72 HRE. # 2024 The Author(s). Published by Elsevier Masson SAS. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
引用
收藏
页码:417 / 428
页数:12
相关论文
共 50 条
  • [1] The C9orf72 hexanucleotide repeat expansion in FTD and ALS
    Eileen H. Bigio
    Nature Reviews Neurology, 2012, 8 : 249 - 250
  • [2] The C9orf72 hexanucleotide repeat expansion in FTD and ALS
    Bigio, Eileen H.
    NATURE REVIEWS NEUROLOGY, 2012, 8 (05) : 249 - 250
  • [3] Role of C9orf72 hexanucleotide repeat expansions in ALS/FTD pathogenesis
    Geng, Yanyan
    Cai, Qixu
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2024, 17
  • [4] The Phenotype of the Hexanucleotide Repeat C9FTD/ALS (C9ORF72)
    Sha, Sharon
    Takada, Leonel
    Rankin, Katherine
    Yokoyama, Jennifer
    Khan, Baber
    Karydas, Anna
    Fong, Jamie
    Rutherford, Nicola
    Baker, Matthew
    DeJesus-Hernandez, Mariely
    Coppola, Giovanni
    Rademakers, Rosa
    Seeley, William
    Miller, Bruce
    Boxer, Adam
    NEUROLOGY, 2012, 78
  • [5] Pathogenic determinants and mechanisms of ALS/FTD linked to hexanucleotide repeat expansions in the C9orf72 gene
    Wen, Xinmei
    Westergard, Thomas
    Pasinelli, Piera
    Trotti, Davide
    NEUROSCIENCE LETTERS, 2017, 636 : 16 - 26
  • [6] Genetic counseling for FTD/ALS caused by the C9ORF72 hexanucleotide expansion
    Fong, Jamie C.
    Karydas, Anna M.
    Goldman, Jill S.
    ALZHEIMERS RESEARCH & THERAPY, 2012, 4 (04)
  • [7] C9ORF72 hexanucleotide repeat expansion in ALS patients from Russia
    Lysogorskaia, E.
    Abramycheva, N.
    Stepanova, M.
    Zakharova, M.
    Illarioshkin, S.
    EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 699 - 699
  • [8] Genetic counseling for FTD/ALS caused by the C9ORF72 hexanucleotide expansion
    Jamie C Fong
    Anna M Karydas
    Jill S Goldman
    Alzheimer's Research & Therapy, 4
  • [9] The ALS/FTD C9ORF72 Hexanucleotide Expansion Disrupts Nucleocytoplasmic Transport
    Zhang, Ke
    Donnelly, Christopher J.
    Haeusler, Aaron R.
    Sattler, Rita
    Wang, Jiou
    Rothstein, Jeffrey D.
    Lloyd, Thomas E.
    ANNALS OF NEUROLOGY, 2014, 76 : S118 - S118
  • [10] C9orf72 hexanucleotide repeat expansion in Turkish ALS patients
    Iskender, C.
    Eken, A. Gundogdu
    Ozoguz, A.
    Akimoto, C.
    Alstermark, H.
    Andersen, P. M.
    Basak, A. N.
    EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 : 328 - 328